TickerFactsScreenerDevelopers

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2007: $4.53B2008: $5.12B2009: $6.53B2010: $7.06B2011: $8.80B2012: $9.66B2013: $9.61B2016: $10.25B2017: $11.24B2018: $9.97B2019: $9.35B2020: $8.93B2021: $8.28B2022: $7.95B2023: $8.20B2024: $8.48B2025: $8.32B$8.32B
2007Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$8.32B-1.9%
2024$8.48B+3.4%
2023$8.20B+3.1%
2022$7.95B-4.0%
2021$8.28B-7.3%
2020$8.93B-4.5%
2019$9.35B-6.3%
2018$9.97B-11.2%
2017$11.24B+9.6%
2016$10.25B—
2013$9.61B-0.6%
2012$9.66B+9.9%
2011$8.80B+24.7%
2010$7.06B+8.0%
2009$6.53B+27.7%
2008$5.12B+12.9%
2007$4.53B—